Form 4 holding
Director
MoonLake Immunotherapeutics
- Security class
- Option to Buy
- Shares / value
- 22,195
- Estimated value
- Report date
- 17 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Class A ordinary shares, par value $0.0001 per share
- Underlying amount